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Abstract
Background: Late adolescence and early adulthood is a period of highest incidence for onset of mental health
problems. Transition to college environment has been associated with many risk factors such as the initial
disruption—and subsequent irregularity—of the student’s sleep and activity schedule. We tested the feasibility of
using blue blocking glasses (BBG) at night in first year higher education students with sleep complaints, to obtain
preliminary evidence for the impact of BBG on sleep, activity, and mood.
Methods: Participants were 13 first year undergraduates (from 10 different academic courses) living on campus for
the first time with sleep complaints/disorders confirmed at screening via the Duke Structured Interview Schedule
for Sleep Disorders. We used a 2-week, balanced crossover design (BBG vs placebo glasses; participants were
unaware which was the active intervention) with computer-generated random allocation. Exploratory analyses
provided descriptive and frequency summaries to evaluate feasibility of the intervention.
Results: Preliminary evidence supports the feasibility and acceptability of the trial; almost all screened participants
consented and completed the protocol with high adherence; missing data were negligible. Additionally, the
effectiveness of BBGs to enhance sleep, mood, and activity levels in young adults was supported.
Conclusions: The results of this feasibility trial suggest that BBG have potential as an inexpensive and feasible
intervention for reducing sleep and circadian dysregulation in young adult students. A larger trial, following
this successfully implemented protocol, is necessary to fully test the efficacy of BBG.
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Late adolescence and early adulthood, a time associated
with newfound independence and excitement for the
future, is also the period of highest incidence for onset
of mental health problems [1]. Research on the prevalence
of mental health disorders on college campuses suggest
that nearly half of students are affected [2, 3].The college
environment is associated with many risk factors for vul-
nerable individuals, including easy access to alcohol and
drugs, and reduced contact with family and existing sup-
port networks. Among the most powerful risk factors may
be the initial disruption—and subsequent irregularity—of
the student’s sleep and activity schedule [4]. In secondary
school, most adolescents live structured lives, bound by
obligations of school, extracurricular activities, family,
parental control, and social life; but for many in college,
classes are infrequent, and at least early on, there are
fewer other obligations to meet, which can lead to irregu-
lar sleep and activity schedules [5, 6]. These risk factors
may be particularly likely to increase risk for mood path-
ology; research has shown that depression is associated
with insomnia and social isolation [7, 8]; and sleep distur-
bances and irregular social behavior are associated with
mania and bipolar disorder [6, 9]. Research suggests that a
young adult, deprived of only one night’s sleep, will experi-
ence greater levels of anger, anxiety, and stress than if s/he
did sleep [7, 10]. Additionally, even relatively minor sleep
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disruptions due to social events or schoolwork can nega-
tively impact daytime functioning and temporarily lower
mood and decrease academic performance [11].
Disturbances of sleep and daily activity interfere with
the circadian rhythm—the body’s clock [5], which is re-
sponsible for maintaining myriad biological processes,
including sleep, metabolism, and energy [12]. The impact
of dysregulated circadian rhythm is evident in other sys-
tems; for example, poor sleep is associated with weight
gain [13]. Importantly, disruptions of the circadian rhythm
and the resulting impact on mental and physical health
are not due only to schedule disruptions; exposure to
blue light—the type emitted from the sky (and from
our omnipresent electronic devices)—is also a factor
[12, 14]. Specifically, specialized retinal ganglion cells
containing melanopsin (OPN4) track levels of blue and
blue-green light (peak sensitivity ~ 470 nm) and signal
the master clock in the brain (the suprachiasmatic nu-
cleus of the hypothalamus [15]), to regulate other body
processes to achieve the appropriate state of alertness
(or sleepiness) based on environmental cues [12, 16]. In
addition to time spent in front of the computer for aca-
demic reasons, young people tend to spend a significant
amount of time in the evening engaging with technol-
ogy—TV, video games, text messaging, etc. On average,
they engage in more than four such activities after 9 pm
[17]. This affects sleep significantly: Most adolescents and
young adults get less than 8 h of sleep during the week—
in many cases directly attributable to electronic device use
[17], the consequences of which include depression, obes-
ity, and poor academic performance [18].
These negative outcomes can derail an individual’s future
[19]. Preventing depression, obesity, and poor academic
performance during this period would be ideal, and evi-
dence suggests that targeting students’ sleep problems can
have broad, positive effects [20]. A new intervention, “vir-
tual darkness” [14, 21], generated by wearing blue blocking
glasses (BBG) may address this need. BBG work by “trick-
ing” the body’s clock into believing that it is nighttime
regardless of the blue light (whether from devices or the
sky) in the environment [21]. Previous research has demon-
strated that BBG can have a potent mood-stabilizing effect
on inpatient adults with bipolar disorder [22] and can regu-
late sleep and improve mood in both healthy people [23]
and postpartum women [24]. Importantly, BBG are a safe
and well-tolerated intervention, positioning “virtual dark-
ness” as a candidate preventive intervention that deserves
further evaluation, particularly in groups in which sleep
disturbance is prominent, like college students.
Our primary aims were to test the feasibility and
acceptability of a balanced crossover design and to
evaluate the effects of BBG in first year higher education
students with sleep complaints. Changing sleep behav-
iors is often difficult [25], and given the unique living
arrangements and social pressures on campus (i.e., stu-
dents live together which creates an environment that
might be incompatible with wearing glasses and/or with
modifying one’s sleep, even if the BBG increased sleep
drive, as expected), we determined that it was necessary
to first test whether participants would follow the study
protocol before launching a larger efficacy trial. Based
on previous research [21, 22], we hypothesized that we
would be able to successfully recruit our target sample
(> 80% of N = 15) and that at least 70% of consented par-
ticipants would complete the trial and demonstrate ad-
equate adherence to the BBG protocol. Further, when
BBG were worn at night for 3 h before target bedtime, we
expected that preliminary evidence would show an effect
in the expected direction of BBG improving sleep, activity,
and mood, compared to a non-BBG intervention.
Method
Design
This study used a 2-week, balanced crossover design
with computer-generated random allocation. The Fac-
ulty of Health and Medicine Research Ethics Committee
(FHMREC), Lancaster University, approved the research
protocol. Participants provided written informed consent.
After protocol completion, participants were debriefed and
received an Amazon voucher worth £75.
Participants
We recruited 13 Lancaster undergraduates (from 10 dif-
ferent academic courses) from October 2015 to April
2016 via advertisements around campus. Sample size
determination was based on pragmatic factors such as
limited resources from pilot grant that payed for up to
15 participants. Inclusion criteria were first year under-
graduates students living on campus for first time with
sleep complaints/disorders confirmed at screening via
the Duke Structured Interview Schedule for Sleep Disor-
ders (DSISD; [26]). We excluded participants if they were
unable or unwilling to comply with protocol; reported
having severe retinal or corneal damage on both eyes; re-
ported daily use of non-steroidal anti-inflammatory drugs,
beta blockers, calcium-antagonist, or central stimulants
like methylphenidate or venlafaxine; reported traveling
outside the UK time zone during the past 2 months; re-
ported changes in hormonal contraceptives during the
past 2 months; or had brain dysfunction as observed dur-
ing the screening interview.
Measures
Participant characteristics (e.g., demographics) and ques-
tionnaires were collected online via Qualtrics software
(2005), Version 3.5.0, Copyright © [2017].
Feasibility outcomes, such as protocol acceptance,
were measured through recording of daily activities via
Perez Algorta et al. Pilot and Feasibility Studies           (2018) 4:166 Page 2 of 7
Qualtrics (e.g., sleep diary completion and BBG wearing
times) and corroborated by objective measurement of
wear times of the actigraph. We collected data about re-
cruitment timeline, and attrition and retention through
database records. At the end of the study, the PI had a
brief debriefing interview with participants, to ask about
the experience of wearing BBG and whether participants
accessed information on BBG from external sources
during trial (which could create an expectancy effect
confounding self-report of some measures of interest in
future studies), and to get any suggestions about improv-
ing tolerability.
Mood ratings
The 7 Up-7 Down [27] is a 14-item self-report scale
carved from the 73-item General Behavior Inventory
[28]. It shows good internal consistency, high correla-
tions with the full length scales, and good discriminative
validity separating cases with mood disorders from other
clinical complaints.
The Positive Affect–Negative Affect Schedule (PANAS)
[29] is one of the most widely used rating scales to meas-
ure positive and negative emotions. It has 10 items of each
valence rated on a Likert-type scale.
Chronotype
At screening, we used the Morningness/eveningness
Questionnaire (MEQ) [30, 31].
Procedure
The PI screened and consented all participants. At
screening, participants were evaluated with the Duke
Structured Interview Schedule for Sleep Disorders (DSISD;
[26]). Baseline measures were repeated at days 3, 7, 10, and
14. Active (sleep log diary) and passive (Actigraphy, Acti-
watch 2, Philips Respironics) activity and sleep data were
collected daily, and sleep time and architecture based on
peripheral arterial tone plus pulse oximetry (WatchPAT200,
Itamar Medical [32] were collected at days 7 and 14.
Baseline data (days 1–3) was collected, and glasses and
procedure were introduced to participants by PI. On day
4, participants previously matched by gender and morn-
ingness/evening preference at screening were randomly
allocated (by computer) to wear either amber (active
BBG; Uvex S1933X with required wave-length-blocking
properties) or blue glasses (non-BBG; Uvex S1932X).
Participants were told by PI that we were testing two
pairs of glasses, each of which filtered different wave-
lengths of light, to reduce the likelihood of participant
expectations about the effects of the BBG versus the
blue glasses). Participants were instructed to put on the
glasses at least 3 h before their target time to fall asleep
until sleep onset each night (e.g., a participant with the
goal of falling asleep at 1 am on day 4 would use the
lenses after 10 pm with instructions to avoid taking
them off until bedroom lights were off ). A washout
period occurred during days 8, 9, and 10 (no glasses).
On day 11, participants crossed over to the other color
of glasses. We asked participants to maintain their regu-
lar sleep-wake schedule during the 2-week period.
Statistical analysis
Exploratory analyses provided descriptive and frequency
summaries to evaluate feasibility of the intervention. Non-
parametric tests (independent-samples Mann-Whitney U
tests) compared medians between groups at night 7 and 14.
Functional linear modeling of actigraphy data [33] investi-
gated patterns of activity during intervention. Hierarchical
linear modeling inspected preliminary evidence of impact of
the intervention on self-report mood measures. Analyses
were conducted in SPSS version 23 using the Actigraphy
package [33] in R [34].
Results
We report data for 12 participants (67% females; age
mean 18.5, SD = .52; 5 White British, 4 Arabic, 2
Hispanic, and 1 Indian) who completed the 2-week
protocol. One participant was unable to participate due to
flooding on campus during scheduled data collection, and
one participant was rejected for having traveled outside
the UK time zone during the past 2 months.
All participants had sleep complaints, and 75% (n = 9)
met criteria for at least one sleep disorder diagnosis (me-
dian age of onset ~ 15). Primary insomnia was most com-
mon (n = 6), followed by inadequate sleep hygiene (n = 4)
(Table 1). None of the participants were currently taking
medication for sleep problems. Three participants re-
ported previously seeking mental health services; none
currently were in pharmacological or/and psychothera-
peutic treatment. The mean number of past mental health
symptoms endorsed at baseline was 2.75 (SD = 3.31), and
an average of 2.25 (SD = 3.31) symptoms were endorsed as
current (range 0 to 12 symptoms, from a maximum pos-
sible of 36 symptoms evaluated using the mental health
problems section of the DSISD [26]. Two participants dis-
closed past headaches. No alcohol or drug problems were
reported, and three were considered heavy consumers of
caffeine (one in the past) based on data collected via
DSISD. Three of five females had irregular cycles; only
one was using contraceptives before study.
Feasibility outcomes
All participants who were screened and eligible for the
trial agreed to take part in the study. Only one partici-
pant refused to participate before screening because of
level of commitment needed to complete daily assess-
ments. We had a retention rate over the 2-week protocol
of 92%; all participants completed the trial. We did not
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make any adjustments to the eligibility criteria or study
design/expectations once recruitment began.
Additionally, adherence to the study requirements was
high. The median number of days wearing glasses was 8
for BBG (range 5 to 8, expected number of days was 8),
and 7.5 for non-BBG (range 4 to 9). The median number
of minutes wearing BBG glasses per day was ~ 196 min
(range 140 to 228, expected minutes 180), and ~ 205 min
for non-BBG (range 138 to 212). No adverse events or
unintended effects were reported.
All 12 participants wore the actigraph watch according
to protocol instructions, and completed all daily assess-
ments via Qualtrics. The level of missing data at item
level was negligible. Seventy percent (n = 9) completed
both peripheral arterial tone and pulse oximetry assess-
ments at night 7 and 14. None of the participants reported
having accessed information about BBG from external
sources such as internet during study. These findings
support the feasibility and acceptability of BBG as a sleep
intervention in university students.
Preliminary sleep, activity, and mood outcomes data
In terms of chronotype (morningness or eveningness
preferences), the sample mean score was 14.58, SD =
3.48, range 9 to 20 from possible range of 0 to 24, where
0 means morningness preference.
In terms of pulse oximetry assessments, non-statistically
significant differences between groups (BBG vs. non-BBG)
were observed when comparing medians at night 7 and 14,
ps > .05 (Table 2). However, those wearing amber glasses
first tended to sleep longer and have fewer awakenings at
night 7 than those wearing blue lenses, a favorable pattern
that reversed at night 14 after participants switched to
wearing blue lenses.
Graphical inspection of 24 h activity levels showed
greater irregularity in those wearing blue, rather than
amber glasses, during baseline days versus during days 4
to 7 (when participants received the intervention for first
time) (Fig. 1). Comparing average trajectories found a
lower level of activity in those wearing amber glasses
during 8 pm to 2 am versus those wearing blue glasses.
Group comparisons during days 11 to 14 were not pos-
sible because of battery performance problems with
some devices during last days of intervention.
Finally, in terms of mood change, we observed a de-
crease in hypomanic-type symptoms in those wearing
amber glasses until day 7 relative to baseline (Fig. 2),
Table 1 Sleep disorder diagnoses based on Duke structured interview schedule for sleep disorders by participant (N = 12)
Sleep Disorder Diagnoses and ID a b c d e f g h i j k l
Primary insomnia, current X X X X X X
Circadian rhythm disorders X
Dyssomnia (Restless legs syndrome, poss.) X
Inadequate sleep hygiene X X X X
Short sleeper X
Insomnia related with MH (depr, past) X
Breathing related sleep disorder, poss. X
Insomnia related with MH (anx, past) X
Parasomnia nos (Legs cramps, current) X
Minimal criteria for insomnia X
Parasomnia nos (Sleep paralysis, past) X
Insomnia related with MH (past&current) X
Nightmare disorder X
Primary Insomnia, past X
No diagnosis X X X
Note: Letters in top horizontal axis represent each study participant. X meet diagnostic criteria for listed condition, poss possible, depr depression, anx anxiety
Table 2 Peripheral arterial tone plus pulse oximetry (WP-200)
results at night 7 and 14 between groups
Night 7 Night 14
Median Range Median Range
Sleep time
Amber first 7:08 5:20–8:18 6:24 4:24–7:32
Blue first 6:47 5:56–7:33 6:44 5:28–8:07
Sleep efficiency
Amber first 85 83–95 84 62–86
Blue first 87 78–94 83 76–92
Awaking times
Amber first 7 2–10 11 6–14
Blue first 9.5 4–15 8 4–16
Non-statistical differences between groups at night 7 and 14 were observed, ps > .06
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Fig. 1 Aggregated 24 h activity level during baseline days versus activity level during days 4 to 7 and comparison of average activity trajectories
Fig. 2 Manic-type symptoms trajectories (measured via Seven Up subscale) by treatment condition. Note. Colors orange and blue represent types
of glasses. Black segments represent baseline or wash-up periods
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differences were not observed during wash-out and
when groups were allocated to blue glasses. Preliminary
analyses using inferential statistics supported this obser-
vation (b = − 1.30, 95% CI [− 2.09, −.79]), and indicated a
trend when analyzing the interaction between time ×
treatment-arm until day 7 (diff in bs = −.88, p < .10). No
differences were observed on changes on depression
scores, or on positive and negative affect scales.
Comments
Recent studies have shown promising results in adults
using blue-blocking glasses at night to improve sleep
and mood. Our goal was to develop and test a protocol
for use with sleep disturbed young adults, supplementing
self-report measures with actigraphy while testing the
feasibility and acceptibility of the intervention in a ran-
domized crossover design. Participants’ report of number
of days wearing BBG glasses at night and self-reported
time wearing glasses both documented a high degree of
acceptability for the intervention with young adults with
sleep complaints. Of importance, no adverse effects were
reported. The success in recruitment and retention, and
the high level of task completion provided another indica-
tor of adherence, with the low percentage of missing data
showing the feasibility of this research project with this
group of young adults with sleep complaints. This feasibil-
ity study, the first one using BBG with young adult stu-
dents with sleep complaints living on campus, supports
the feasibility of running this crossover design study. It
also offers preliminary evidence about the potential use of
this intervention to address challenges associated with risk
factors of mental health onset or exacerbation of current
symptoms for vulnerable individuals. In particular, the
sleep profile observed in this sample resembles difficulties
observed in clinical populations. The intervention was
well accepted by this young group.
Preliminary evidence supported the positive impact of
wearing BBG on sleep. Inspection of activity levels dur-
ing days, and reduction of hypomanic-type symptoms in
this sample, also provide preliminary evidence supporting
the so called “deactivation hypothesis” associated with the
impact of wearing BBG at night on noradrenergic path-
ways proposed by Henrisksen et al. [22].
In future studies with big samples of university students,
there are some aspects that require further consideration,
for example, wearing glasses maybe uncomfortable for
some people, in particular for those already wearing regu-
lar glasses. Also, the potential impact of widespread publi-
city about blue light and BBG potentially may contribute
to an expectancy effects (although these are less likely to
affect actigraphy than self-report measures).
Because tinted glasses are widely used for fashion and
other reasons, BBG could also offer a non-stigmatizing
treatment option for this young adult population. It is
also likely that BBG offer benefits beyond other options
for reducing blue light exposure, such as apps that
change the color composition of the images displayed on
computers and hand-held electronics in the evening
hours, because they block blue light from all environ-
mental sources, including the television or LED lights.
However, an important step in this research is to com-
pare the relative impact of BBG and alternative methods
directly. Finally, BBG are an appealing intervention in
terms of adherence, compatible with student daily rou-
tines and recreational activities (e.g., use of social media
and gaming via electronic devices).
Limitations
This study needs replication given the small sample size,
and potential impact of design characteristics, in particu-
lar length of wash-out period on carry-over effects of
BBG. Notably, all findings observed ran in the expected
direction, supporting the potential use of BBG to target
difficulties associated with circadian dysregulation, such
as sleep or mood difficulties. However, given the small
sample size, our analyses were not adequately powered
and should be considered preliminary, pending replica-
tion in a larger, adequately powered efficacy study.
Conclusions
Wearing BBG at night shows promise as an inexpensive
and feasible intervention for reducing problems associ-
ated with circadian dysregulation for young adults as
well as adults. Larger studies with non-clinical and
young clinical samples (inpatients and outpatients)
should unpack the effects on cognitive functioning as
well as mood and activity, as well as inform the develop-
ment of more refined protocols for timing and otherwise
improving sleep hygiene and implementation.
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